Literature DB >> 9844050

Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.

F J Medrano1, C Rey, M Leal, C Cañavate, A Rubio, A Sánchez-Quijano, J Alvar, E Lissen.   

Abstract

Serum cytokine levels and peripheral T cell subpopulations of HIV-1-infected patients before, during and after active visceral leishmaniasis (VL) were analysed and compared with appropriate controls. At VL diagnosis, co-infected patients showed higher serum levels of interferon-gamma (IFN-gamma) than matched HIV-1 controls without VL, and lower serum concentrations of IL-10 than non-immunocompromised VL controls. High levels of tumour necrosis factor-alpha (TNF-alpha) and IFN-gamma were present in the sera of HIV-1-infected patients with active VL. TNF-alpha remained elevated after VL recovery. A steady decline in the CD4+ cell count, an increase of serum HIV viraemia and a progressive seroconversion for the HIV-1 p24 antigen was observed during the course of VL disease. Thus, an aberrant activation of the TNF system with possible negative immunological and virological consequences is present in HIV-1-infected patients with VL. A more extensive prospective validation of these findings in a bigger cohort of patients will nevertheless be necessary. The results support the hypothesis that different opportunistic infection agents may trigger the production of proinflammatory cytokines during immunodeficiency, and in this way accelerate the course of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844050      PMCID: PMC1905121          DOI: 10.1046/j.1365-2249.1998.00733.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

Review 1.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

Review 3.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

4.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals.

Authors:  C Graziosi; G Pantaleo; K R Gantt; J P Fortin; J F Demarest; O J Cohen; R P Sékaly; A S Fauci
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

5.  Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.

Authors:  J W Mellors; B P Griffith; M A Ortiz; M L Landry; J L Ryan
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

6.  Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy.

Authors:  P Cenini; N Berhe; A Hailu; K McGinnes; D Frommel
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

Review 7.  Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function.

Authors:  R M Locksley; P Scott
Journal:  Immunol Today       Date:  1991-03

8.  Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?

Authors:  F J Medrano; J Hernández-Quero; E Jiménez; J A Pineda; A Rivero; A Sánchez-Quijano; I D Velez; P Viciana; R Castillo; M J Reyes
Journal:  AIDS       Date:  1992-12       Impact factor: 4.177

9.  Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters.

Authors:  P Aukrust; N B Liabakk; F Müller; E Lien; T Espevik; S S Frøland
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

10.  Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion.

Authors:  N Oyaizu; T W McCloskey; S Than; R Hu; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more
  7 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Serum cytokine levels in human ascariasis and toxocariasis.

Authors:  Nancy Malla; Bashir Ahmad Fomda; Manzoor Ahmad Thokar
Journal:  Parasitol Res       Date:  2005-12-28       Impact factor: 2.289

Review 3.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients.

Authors:  Maria Luciana Silva-Freitas; Glaucia Fernandes Cota; Talia S Machado-de-Assis; Carmem Giacoia-Gripp; Ana Rabello; Alda M Da-Cruz; Joanna R Santos-Oliveira
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 5.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

Review 6.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 7.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.